Related Experiment Video

Updated: May 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells

Lujia Gribben1, Robert C Baxter, Deborah J Marsh

  • 1Hormones & Cancer Division, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia.

Cancer Letters
|November 17, 2011
PubMed

Insights

Endometrial cancer (EC) cell migration is slowed by insulin-like growth factor protein-3 (IGFBP-3). Lowering IGFBP-3 speeds up EC cell migration and invasion, suggesting IGFBP-3

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Endocrinology

Background:

  • Endometrial cancer (EC) metastasis, driven by cell migration and invasion, is a primary cause of cancer-related mortality.
  • The role of insulin-like growth factor protein-3 (IGFBP-3) in regulating EC cell behavior, particularly migration and invasion, remains incompletely understood.

Purpose of the Study:

  • To investigate the functional role of endogenous insulin-like growth factor protein-3 (IGFBP-3) in modulating endometrial cancer (EC) cell migration and invasion dynamics.
  • To determine the relationship between IGFBP-3 expression levels and the migratory phenotype of EC cells.

Main Methods:

  • Utilized small interfering RNA (siRNA) to down-regulate IGFBP-3 expression in EC cells.
  • Assessed cell migration and proliferation rates following IGFBP-3 modulation.
  • Examined cell morphology and the localization of migration-associated markers.
  • Investigated the effects of recombinant IGFBP-3 addition and IGFBP-3 overexpression.
  • Correlated IGFBP-3 expression with PTEN mutation status and migration rates.

Main Results:

  • Down-regulation of IGFBP-3 using siRNA significantly accelerated EC cell migration and invasion without affecting proliferation.
  • EC cells with reduced IGFBP-3 exhibited a more migratory phenotype, with key markers localizing to the cell membrane's leading edge.
  • Conversely, addition of recombinant IGFBP-3 or IGFBP-3 overexpression inhibited cell migration.
  • Cells with mutated PTEN demonstrated the highest IGFBP-3 levels and the slowest migration rates.

Conclusions:

  • Endogenous IGFBP-3 acts as a crucial modulator of adhesion-migration dynamics in endometrial cancer cells.
  • IGFBP-3 expression levels are inversely correlated with EC cell migratory potential.
  • These findings suggest that IGFBP-3 plays a significant role in regulating endometrial cancer metastasis and may represent a potential therapeutic target.

More Related Videos

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion06:36

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion

Published on: April 24, 2015

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model

Published on: June 11, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...